Increasing Use Of Interferon Gamma Release Assays Among Children ≥2 Years of Age in a Setting With Low Tuberculosis Prevalence
Jeffrey I. Campbell, Mary Tabatneck, Mingwei Sun, Wei He, Nicholas Musinguzi, Bethany Hedt‐Gauthier, Gabriella S Lamb, Don Goldmann, et al. (11 authors)
The Pediatric Infectious Disease Journal · 2022-10
Abstract
US guidelines recommend interferon gamma release assays (IGRAs) for diagnosis of tuberculosis infection in children. In this retrospective cohort study, IGRA use in children 2-17 years of age increased substantially between 2015 and 2021. Testing in inpatient/subspecialty settings (vs. primary care), public (vs. private) insurance, lower age and non-English preferred language were associated with increased odds of receiving an IGRA.
MeSH terms
- Medicine
- Tuberculosis
- Retrospective cohort study
- Interferon gamma release assay
- Odds
- Cohort
- Odds ratio
- Pediatrics
- Subspecialty
- Mycobacterium tuberculosis
- Family medicine
- Internal medicine
- Immunology